These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22968527)

  • 1. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
    Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
    BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
    Perel P; Prieto-Merino D; Shakur H; Roberts I
    Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
    Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
    Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    ; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S; Herrera J; Hunt B; Iribhogbe P; Izurieta M; Khamis H; Komolafe E; Marrero MA; Mejía-Mantilla J; Miranda J; Morales C; Olaomi O; Olldashi F; Perel P; Peto R; Ramana PV; Ravi RR; Yutthakasemsunt S
    Lancet; 2010 Jul; 376(9734):23-32. PubMed ID: 20554319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
    ; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
    Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
    Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
    West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
    Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
    Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial.
    CRASH-3 trial collaborators
    Lancet; 2019 Nov; 394(10210):1713-1723. PubMed ID: 31623894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial.
    Nishijima DK; Kuppermann N; Roberts I; VanBuren JM; Tancredi DJ
    Ann Emerg Med; 2019 Jul; 74(1):79-87. PubMed ID: 30642657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study).
    CRASH-2 Collaborators, Intracranial Bleeding Study
    BMJ; 2011 Jul; 343():d3795. PubMed ID: 21724564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators
    Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nested mechanistic sub-study into the effect of tranexamic acid versus placebo on intracranial haemorrhage and cerebral ischaemia in isolated traumatic brain injury: study protocol for a randomised controlled trial (CRASH-3 Trial Intracranial Bleeding Mechanistic Sub-Study [CRASH-3 IBMS]).
    Mahmood A; Roberts I; Shakur H
    Trials; 2017 Jul; 18(1):330. PubMed ID: 28716153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.
    Roberts I; Coats T; Edwards P; Gilmore I; Jairath V; Ker K; Manno D; Shakur H; Stanworth S; Veitch A
    Trials; 2014 Nov; 15():450. PubMed ID: 25409738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial.
    Roberts I; Prieto-Merino D; Manno D
    Crit Care; 2014 Dec; 18(6):685. PubMed ID: 25498484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
    Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid in trauma: how should we use it?
    Roberts I
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S195-9. PubMed ID: 26149023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
    Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
    Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.